School of Medicine - News

Selected to the Academy of Finland’s Flagship Programme for the years 2020–2024, the GeneCellNano Flagship seeks to speed up the introduction of new biological drugs for severe chronic diseases. The Flagship is led by Academy Professor Seppo Ylä-Herttuala.

A new study sheds light on the role of diabetes in the cellular and molecular changes underlying Alzheimer's disease (AD).

Approximately one third of adult Finns have temporomandibular disorders. TMD patients don't get additional benefit from stabilization splint treatment, according to the doctoral dissertation by Veera Qvintus, DDS.

Several UEF researchers representing the fields of medicine and molecular medicine were ranked in world's top 10,000 scientists for career-long impact. Ranked in the top 100 in their own field were particularly researchers representing forest sciences.

The use of a specifically formulated multinutrient drink in early Alzheimer’s disease slowed down the deterioration of memory and cognitive functions as well as whole brain atrophy.

Individualised and family-based physical activity and dietary counselling considerably slows down the development of insulin resistance.

Vaginal delivery and breastfeeding supported the development of asthma protection associated gut microbiota at the age of two months.

Subtler symptoms often go undiagnosed long enough to cause unexpected seizures that contribute to car crashes.